All lobbying filings

SIDLEY AUSTIN LLP

SIDLEY AUSTIN LLP filed a Q2 report for KARYOPHARM THERAPEUTICS on July 20, 2026.

Lobbying for KARYOPHARM THERAPEUTICS · Pharmaceutical manufacturer

All filings by SIDLEY AUSTIN LLP · Everything KARYOPHARM THERAPEUTICS has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Massachusetts

Official filing document

Lobbyists on this filing 2

PATRICIA LOUISE DELOATCHE

Previously held: Health Policy Director, Sen Orrin Hatch; Chief of Staff, Legislative Director, Legislative Assistant, Rep. Mike Bilirakis
ABIGAIL CARROLL

Previously held: Detailee to the Energy and Commerce Committee, U.S House of Representatives

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Rare disease policy, drug approval process

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.